← Back to all trials
Active Not Recruiting
NCT05471128
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
Conditions: Prostate Cancer
Sex: Male
Ages: 18 Years – 99 Years
Enrollment: 29
Sponsor: University of Oklahoma
Location: University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City Oklahoma
Summary
The purpose of this study is to find out how best to detect clinically significant lesions of prostate cancer by using micro-ultrasound technology (ExactVu) and by multiparametric magnetic-resonance imaging (mpMRI).
Eligibility Criteria
Inclusion Criteria:
1. Patients scheduled to undergo biopsy and with one of the following:
* Men with suspicion of prostate cancer
* Men on active surveillance
2. Age ≥18 \[30\]
3. Have available multiparametric prostate MRI
4. Able to provide written, informed consent
5. No significant medical illness which in the opinion of the Investigator would preclude entry to study procedures
6. Be willing and able to comply with scheduled visits
Exclusion Criteria:
1. Previously confirmed prostate cancer diagnosis with Grade Group \>= 2
2. Unable to undergo prostate biopsy
3. Prostate MRI unable to be evaluated using the PI-RADS v2 criteria
4. Men with contraindication for MRI or a prostate biopsy
5. Prostate biopsy within 8 weeks prior to mpMRI.
6. Any history of prostate treatment
Source: ClinicalTrials.gov (NCT05471128). StuddyBuddy aggregates publicly available trial information.
